13F HOLDINGS REPORT
Northpond Ventures, LLC
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001104659-24-061943
Total Value
$102.6M
Positions
4
Other Managers
0
Confidential Omitted
No
Holdings (4)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | KYVERNA THERAPEUTICS INC | KYTX | 3,255,426 | $80.9M | 78.80% |
| 2 | VIGIL NEUROSCIENCE INC | 92673K108 | 4,214,498 | $14.4M | 14.00% |
| 3 | TELESIS BIO INC | 192003101 | 9,844,130 | $4.3M | 4.22% |
| 4 | CANDEL THERAPEUTICS INC | CADL | 1,935,215 | $3.1M | 2.98% |